Pages G - Search Results

1

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma.

Polena H, Creuzet J, Dufies M, Sidibé A, Khalil-Mgharbel A, Salomon A, Deroux A, Quesada JL, Roelants C, Filhol O, Cochet C, Blanc E, Ferlay-Segura C, Borchiellini D, Ferrero JM, Escudier B, Négrier S, Pages G, Vilgrain I. Polena H, et al. Among authors: pages g. Br J Cancer. 2018 May;118(9):1179-1188. doi: 10.1038/s41416-018-0054-5. Epub 2018 Mar 22. Br J Cancer. 2018. PMID: 29563634 Free PMC article.

2

Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance.

Onesto C, Hannoun-Lévi JM, Chamorey E, Formento JL, Ramaioli A, Pagès G. Onesto C, et al. Among authors: pages g. Br J Cancer. 2006 May 22;94(10):1516-23. doi: 10.1038/sj.bjc.6603108. Br J Cancer. 2006. PMID: 16641910 Free PMC article.

3

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity.

Beauclair S, Formento P, Fischel JL, Lescaut W, Largillier R, Chamorey E, Hofman P, Ferrero JM, Pagès G, Milano G. Beauclair S, et al. Among authors: pages g. Ann Oncol. 2007 Aug;18(8):1335-41. doi: 10.1093/annonc/mdm181. Ann Oncol. 2007. PMID: 17693647 Free article. Clinical Trial.

4

Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: a new paradigm for understanding the therapeutic effect of combined treatment.

Ortholan C, Durivault J, Hannoun-Levi JM, Guyot M, Bourcier C, Ambrosetti D, Safe S, Pagès G. Ortholan C, et al. Among authors: pages g. Eur J Cancer. 2010 Nov;46(16):3022-36. doi: 10.1016/j.ejca.2010.07.021. Epub 2010 Aug 20. Eur J Cancer. 2010. PMID: 20729074

5

Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.

Grepin R, Guyot M, Jacquin M, Durivault J, Chamorey E, Sudaka A, Serdjebi C, Lacarelle B, Scoazec JY, Negrier S, Simonnet H, Pages G. Grepin R, et al. Among authors: pages g. Oncogene. 2012 Mar 29;31(13):1683-94. doi: 10.1038/onc.2011.360. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909141

6

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.

Grépin R, Guyot M, Giuliano S, Boncompagni M, Ambrosetti D, Chamorey E, Scoazec JY, Negrier S, Simonnet H, Pagès G. Grépin R, et al. Among authors: pages g. Cancer Res. 2014 Feb 1;74(3):873-83. doi: 10.1158/0008-5472.CAN-13-1267. Epub 2013 Dec 12. Cancer Res. 2014. PMID: 24335961

7

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Grépin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F, Pagès G. Grépin R, et al. Among authors: pages g. PLoS One. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449. eCollection 2014. PLoS One. 2014. PMID: 24676409 Free PMC article.

8

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.

Giuliano S, Cormerais Y, Dufies M, Grépin R, Colosetti P, Belaid A, Parola J, Martin A, Lacas-Gervais S, Mazure NM, Benhida R, Auberger P, Mograbi B, Pagès G. Giuliano S, et al. Among authors: pages g. Autophagy. 2015;11(10):1891-904. doi: 10.1080/15548627.2015.1085742. Autophagy. 2015. PMID: 26312386 Free PMC article.

9

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E, Parola J, Vial V, Lupu-Plesu M, Bernhard JC, Ravaud A, Borchiellini D, Ferrero JM, Bikfalvi A, Ebos JM, Khabar KS, Grépin R, Pagès G. Dufies M, et al. Among authors: pages g. Cancer Res. 2017 Mar 1;77(5):1212-1226. doi: 10.1158/0008-5472.CAN-16-3088. Epub 2017 Jan 13. Cancer Res. 2017. PMID: 28087600

10

Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides.

Alaoui S, Dufies M, Driowya M, Demange L, Bougrin K, Robert G, Auberger P, Pagès G, Benhida R. Alaoui S, et al. Among authors: pages g. Bioorg Med Chem Lett. 2017 May 1;27(9):1989-1992. doi: 10.1016/j.bmcl.2017.03.018. Epub 2017 Mar 9. Bioorg Med Chem Lett. 2017. PMID: 28325600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters